Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aberle

Showing results (681-690 of 837) with videos related to

Pageof 84
Sort By:
Diabetes, Obesity & Metabolism|March 24, 2018
Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control studyKatharina Laubner, Nina Riedel, Katharina Fink, et al.
Vaccines|August 28, 2021
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after VaccinationNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
Journal of Hepatology|February 24, 2009
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variabilityLukas Weseslindtner, Christoph Neumann-Haefelin, Sergei Viazov, et al.
Lancet (London, England)|November 23, 2025
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trialDeborah B Horn, Donna H Ryan, Sanja Giljanovic Kis, et al.
Lancet (London, England)|June 8, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trialVanita R Aroda, Melanie J Davies, Jill Maaske, et al.
Frontiers in Medicine|January 24, 2022
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated NephropathyHaris Omić, Johannes Phillip Kläger, Harald Herkner, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|March 26, 2024
Proposed DRLs for mammography in SwitzerlandLaura Dupont, Christoph Aberle, Diomidis Botsikas, et al.
NPJ Parkinson'S Disease|April 21, 2025
Microstructure is associated with motor outcomes following Deep Brain Stimulation in Parkinson's diseasePhilipp Alexander Loehrer, Julia Freigang, Miriam H A Bopp, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Safety and efficacy of pasireotide in dumping syndrome-results from a phase 2, multicentre studyJ Tack, J Aberle, J Arts, et al.
Plos One|March 11, 2015
Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2Christina Fieber, Marton Janos, Tina Koestler, et al.
Pageof 84

Showing results (681-690 of 837) with videos related to

Sort By:
Pageof 84
Diabetes, Obesity & Metabolism|March 24, 2018
Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control studyKatharina Laubner, Nina Riedel, Katharina Fink, et al.
Vaccines|August 28, 2021
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after VaccinationNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
Journal of Hepatology|February 24, 2009
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variabilityLukas Weseslindtner, Christoph Neumann-Haefelin, Sergei Viazov, et al.
Lancet (London, England)|November 23, 2025
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trialDeborah B Horn, Donna H Ryan, Sanja Giljanovic Kis, et al.
Lancet (London, England)|June 8, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trialVanita R Aroda, Melanie J Davies, Jill Maaske, et al.
Frontiers in Medicine|January 24, 2022
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated NephropathyHaris Omić, Johannes Phillip Kläger, Harald Herkner, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|March 26, 2024
Proposed DRLs for mammography in SwitzerlandLaura Dupont, Christoph Aberle, Diomidis Botsikas, et al.
NPJ Parkinson'S Disease|April 21, 2025
Microstructure is associated with motor outcomes following Deep Brain Stimulation in Parkinson's diseasePhilipp Alexander Loehrer, Julia Freigang, Miriam H A Bopp, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Safety and efficacy of pasireotide in dumping syndrome-results from a phase 2, multicentre studyJ Tack, J Aberle, J Arts, et al.
Plos One|March 11, 2015
Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2Christina Fieber, Marton Janos, Tina Koestler, et al.
Pageof 84